Treating Crohn's Disease by Inducing T Lymphocyte Apoptosis
- 1 November 2002
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 973 (1) , 166-180
- https://doi.org/10.1111/j.1749-6632.2002.tb04628.x
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Cellular environments and apoptosis: tissue microenvironments control activated T-cell deathImmunology Today, 1997
- Advances in Mucosal ImmunityDrugs, 1997
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Interleukin-10 gene knock-out mice: a model of chronic inflammationClinical Immunology and Immunopathology, 1995
- Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteasesEuropean Journal of Immunology, 1995
- Transfer of CD4+ T cells to C.B-17 SCID mice: a model to study Th1 and Th2 cell differentiation and regulation in vivoResearch in Immunology, 1994
- Activation-induced cell death (apoptosis) of mature peripheral T lymphocytesImmunology Today, 1993
- Lymphocyte lifespans: homeostasis, selection and competitionImmunology Today, 1993
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991